By Business/Source
Currency:CNY
2025/FY
Stock NameRevenueRatio
Sale of pharmaceutical products101.06M95.94%
授权及合作收入4.28M4.06%
By Product
Currency:CNY
2025/FY
Stock NameRevenueRatio
Sale of pharmaceutical products101.06M95.94%
授权及合作收入4.28M4.06%
By Country/Region
Currency:CNY
2025/FY
Stock NameRevenueRatio
The mainland of China85.73M81.38%
Other countries / regions19.61M18.62%
